Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

800 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-06

Study Completion Date

2023-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hospitals aim to hospitalize patients when necessary and discharge patients when possible. However, the triage process and discharge management of patients in e.g. the Acute Admission Ward, is not a trivial task. The upcoming technology of wearable monitoring devices, whereby patients can be continuously monitored with an unobtrusive vital signs device, might help getting more insight into patients' health condition and thus help facilitate efficient and effective triaging.

Therefore, the primary objective is to assess the effects of continuous monitoring of patients in the acute admission ward (AAW) on the percentage of patients who can be discharged home. Secondary objectives are to assess the length of stay in the acute admission ward and in the in-hospital wards, as well as the effect on admission to the intensive care unit, rapid response team calls and hospital readmission. The predictive value of algorithms applied to the monitoring data combined with other parameters to detect timely deterioration and predict discharge will be assessed. Facilitators and barriers for implementing such a system will be investigated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Suitability of Unobtrusive Bed Monitoring and Wrist-worn Heart Rate Monitor for Patient Monitoring

NCT03572751

Arrhythmia Hemorrhage Septic Shock +2 more

COMPLETED

Clinical Outcomes After Implementation of COntinuous Vital Sign Monitoring On the General Ward.

NCT04189653

Clinical Deterioration

COMPLETED

Accuracy Activity Monitors for Inhospital Activity Monitoring of Geriatric Patients

NCT04865627

Hip Fractures Stroke Abdominal Injury

COMPLETED

Video Monitoring FOR Early Signaling of Adverse EvEnts, Technical Validation

NCT05455775

Vital Signs

COMPLETED

Automated Alerts of Patient Deterioration vs. Routine Monitoring of High-risk Patients Admitted to Medical Wards

NCT04661748

Alert Fatigue, Health Personnel Deterioration, Clinical

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Monitoring Clinical Deterioration Acute Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Monitoring Group

wearable sensor, besides usual care monitoring

Group Type EXPERIMENTAL

Wearable Sensor

Intervention Type DEVICE

The sensor measures vital signs including heart rate and respiratory rate, posture and level of physical activity.

Usual Care

Intervention Type OTHER

Usual Care Monitoring

Usual Care group

usual care monitoring

Group Type OTHER

Usual Care

Intervention Type OTHER

Usual Care Monitoring

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wearable Sensor

The sensor measures vital signs including heart rate and respiratory rate, posture and level of physical activity.

Intervention Type DEVICE

Usual Care

Usual Care Monitoring

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Philips Healthdot

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

In order for a patient to be eligible to participate in this study, the following criteria need to be met:

* admitted to the AAW
* Age ≥ 18 years
* Able to speak and read Dutch
* Willing and able to provide written informed consent

Exclusion Criteria

A patient who meets any of the following criteria will be excluded from participation:

* Not able or willing to wear a wearable sensor on the chest continuously for 14 days
* Planned major surgery in the upcoming 30 days
* At the time of AAW admission already known to be discharged home or admitted to the hospital
* Any skin condition, for example prior rash, discoloration, scars, infection, injury or open wounds at the area (Left lower rib) where the sensor needs to be placed
* Known sensitivity to medical adhesives
* Wearing an active implantable device (e.g. ICD, pacemaker)
* Intend to go to the sauna or go swimming in the upcoming 14 days
* Pregnant or breastfeeding
* Use of creams or lotions that are known to influence the skin at the area where sensor is placed (such as medical and non-medical creams or lotions)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No